Skip to main content
Equibles

MORGAN STANLEY

Position in ENLV — Enlivex Ltd.

CIK 895421 NEW YORK, NY
Back to ENLV Full portfolio

Position in ENLV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,673
-$86,776 QoQ
Shares Held
566
-91.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 25 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ENLV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. ENLV ranks #438 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in ENLV

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,673 8,497
2026-03-31 $91,449 98,333
2025-12-31 $141,040 200,627
2025-09-30 $180,570 173,625
2025-06-30 $245,446 219,149
2025-03-31 $223,764 230,685
2024-12-31 $315,496 269,655
2024-09-30 $412,866 245,754
2024-06-30 $347,745 244,892
2024-03-31 $273,334 72,120
2023-12-31 $120,041 44,460
2023-09-30 $69,766 44,156
2023-06-30 $115,196 43,851
2023-03-31 $146,178 40,159
2022-12-31 $160,378 40,726
2022-09-30 $189,191 44,516
2022-06-30 $147,917 32,725
2022-03-31 $120,604 21,575
2021-12-31 $107,256 17,161
2021-09-30 $183,204 18,543
2021-06-30 $125,507 14,102
2021-03-31 $172,238 15,531
2020-12-31 $23,654 2,806
2020-06-30 $10 2
2020-03-31 $131,736 28,149